Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07420075

Alzheimer's Registry

PPD™ CorEvitas™ International Alzheimer's (ALZ) Drug Safety and Effectiveness Registry

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
CorEvitas · Network
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The design is an open-ended, prospective, observational, (non-interventional) registry for subjects with mild cognitive impairment (MCI), early symptomatic Alzheimer's disease, Alzheimer's disease, or dementia with clinical suspicion of Alzheimer's disease under the care of a neurologist, psychiatrist, geriatrician or other qualified provider. Longitudinal data are collected from subjects, their care partner(s), and their treating healthcare provider during routine clinical encounters using a structured and standardized data collection method. Approximately 2,000 subjects, with no defined upper limit, across around 75 clinical sites worldwide will be recruited.

Detailed description

The objective of the registry is to create a prospective cohort of Alzheimer's disease subjects to evaluate long-term real-world safety and effectiveness of standard of care treatments for Alzheimer's disease. Data collected through the registry may be used to address a range of research questions and use cases, including but not limited to: Evaluating the effectiveness and safety of commercially available medications for the treatment of Alzheimer's disease, Providing information to support ongoing risk-benefit evaluation by drug manufacturers and regulators, Research related to drug utilization, disease burden, and unmet needs and Supporting post-authorization safety studies to generate evidence related to real world safety of medications used for the treatment of the disease(s) under study

Conditions

Timeline

Start date
2025-11-24
Primary completion
2099-12-31
Completion
2099-12-31
First posted
2026-02-19
Last updated
2026-02-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07420075. Inclusion in this directory is not an endorsement.

Alzheimer's Registry (NCT07420075) · Clinical Trials Directory